ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Respiratory Tract Diseases
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy
Conjunctivitis

Asthma trials near London, England, GBR:

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (ARRIVAL)

administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...

Active, not recruiting
Severe Asthma
Combination Product: Budesonide/formoterol
Combination Product: Mannitol

Phase 3

AstraZeneca
AstraZeneca

London, United Kingdom and 70 other locations

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

London, United Kingdom and 87 other locations

This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation...

Enrolling
Asthma Acute
Combination Product: Rademikibart in prefilled syringe
Drug: Matching placebo in prefilled syringe

Phase 2

Connect Biopharm LLC

London, United Kingdom and 40 other locations

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...

Active, not recruiting
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

Phase 2

Upstream Bio

Chertsey, Surrey, United Kingdom and 155 other locations

12 years old with moderate to severe asthma....

Enrolling
Asthma
Drug: Glycopyrronium bromide 25ug
Drug: Glycopyrronium bromide 12.5ug

Phase 2

Novartis
Novartis

London, United Kingdom and 22 other locations

The United Kingdom has a high prevalence of asthma (over 12%) and some of the worst health outcomes in Europe. The management of respiratory...

Enrolling
Asthma Chronic
Device: Aptar Digital Health respiratory disease management platform
CoheroHealth

London, England, United Kingdom

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

London, United Kingdom and 335 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

London, United Kingdom and 139 other locations

A Phase IIa trial in participants with asthma to evaluate the impact of intranasal ETH47 on the development of asthma-related sympt...

Enrolling
Asthma (Diagnosis)
Drug: Placebo
Drug: ETH47

Phase 2

Ethris GmbH

London, United Kingdom

This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an exis....

Enrolling
Asthma
Drug: CHF5993 pMDI with HFA-134a
Drug: CHF5993 pMDI with HFA-152a

Phase 2

Chiesi
Chiesi

Dagenham, United Kingdom

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems